CERT Stock Summary and Trading Ideas (Certara | NASDAQ:CERT)

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Certara trades on the NASDAQ stock market under the symbol CERT.

As of January 28, 2026, CERT stock price declined to $9.49 with 155,636 million shares trading.

CERT has a beta of 1.72, meaning it tends to be more sensitive to market movements. CERT has a correlation of 0.22 to the broad based SPY ETF.

CERT has a market cap of $1.51 billion. This is considered a Small Cap stock.

Last quarter Certara reported $105 million in Revenue and $.14 earnings per share. This fell short of revenue expectation by $-216,838 and exceeded earnings estimates by $.05.

In the last 3 years, CERT traded as high as $24.96 and as low as $8.03.

The top ETF exchange traded funds that CERT belongs to (by Net Assets): IJR, VTI, VB, VBK, VXF.

CERT has underperformed the market in the last year with a return of -29.2%, while the SPY ETF gained +17.6%. In the last 3 month period, CERT fell short of the market, returning -24.1%, while SPY returned +2.1%. However, in the most recent 2 weeks CERT has outperformed the stock market by returning +3.7%, while SPY returned +0.5%.

CERT support price is $9.42 and resistance is $9.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT shares will trade within this expected range on the day.